Based on the BRCA data from the TCGA database, we confirmed the higher expression of EIF3B compared in 112 pairs of BRCA tissues and matched non-cancer tissues (Figure 5(a)), and the EIF3B expression level was significantly related to the pathologic stage (Figure 5(b)). The gene discussed is EIF3B; the disease is cancer.